From Candy to Controversy: The FDA’s Ban on Red Dye No 3
On January 15, 2025, the United States Food and Drug Administration (FDA) made a landmark decision to ban the use of Red Dye ...
Trump Orders CDC, FDA, and Other Health Agencies to Go Dark
The Centers for Disease Control and Prevention is going dark, along with other federal agencies within the umbrella of the ...
FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
US FDA puts clinical hold on Atara's trials for cancer cell therapies
Atara Biotherapeutics said on Tuesday the U.S. health regulator has placed a clinical hold on its trials for cancer cell ...
US FDA approves AstraZeneca's drug for breast cancer
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
US FDA approves Amgen's colorectal cancer therapy
The U.S. Food and Drug Administration approved Amgen's combination therapy on Thursday to treat colorectal cancer in patients ...
BusinessMirror16h
US FDA removes coconut from food allergen list–PCA
The exclusion of coconut as a major food allergen eases trade barriers for coconut-based products in the US market, according to the Philippine Coconut Authority (PCA). This, after the US Food and ...
cnbctv1816h
Laurus Labs' US arm gets Form 483 from FDA after 'adverse experience' probe
The inspection focused on the subsidiary's practices and procedures related to Laurus Labs’ marketed products worldwide.
FDA approves Spravato, first monotherapy nasal spray to treat depression
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.